Lumateperone Tosylate API Manufacturer and Supplier

API Solutions

Dr. Reddy's API business supplies high-quality, affordable APIs to leading generic formulations manufacturers and is the preferred API partner for pharma companies in more than 100 countries.

R&D

Dr. Reddy’s supplies generic APIs to 80+ countries, excelling in R\&D across niche molecules and key therapies, with capabilities from lab to production in contained/non-contained APIs and advanced chemical processes.

White Paper

Dr. Reddy’s offers insightful whitepapers sharing expertise on APIs, formulations, regulatory trends, and industry innovations, helping global pharma partners gain knowledge, solve challenges, and drive faster, compliant product development.

About Lumateperone Tosylate API

Therapeutic Category Central Nervous System (CNS)
CAS Number
313368-91-1
API Technology
Synthetic
Dose Form
Oral Solid/Capsules
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, Brazil DMF

Mechanism of Action

The mechanism of action of lumateperone in the treatment of schizophrenia is unknown. However, the efficacy of lumateperone could be mediated through a combination of antagonist activity at central serotonin 5-HT2A receptors and postsynaptic antagonist activity at central dopamine D2 receptors.

Indication

CAPLYTA is an atypical antipsychotic indicated for the treatment of schizophrenia in adults.

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Related APIs

Edaravone

Central Nervous System (CNS)

Fluoxetine

Central Nervous System (CNS)

Levetiracetam

Central Nervous System (CNS)

Memantine Hydrochloride

Central Nervous System (CNS)

Xanomeline

Central Nervous System (CNS)

Eslicarbazepine Acetate

Central Nervous System (CNS)